COVID-19 Testing
Detection Principle
review
Target
mixed
Testing Method Category
In_silico
Testing Method
meta-analysis
Testing Method - Additional Info
Impact of Prevalence, Sensitivity, and Specificity on Patient Risk and Cost
Reported Performance
Sensitivity: 86% (molecular tests), 61% (Antigen), 68% (Antibody); Specificity: 95.8% (molecular tests), 98.2% (Antigen), 95.6% (Antibody). Remark: Molecular and antigen tests are relevant in the acute phase only. Serologic assays detect antibodies to SARS-CoV-2 in the recovering and recovered phase
Sample Size
/
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements